Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.64 |
| ▸ | ITGA2B | P08514 | 19/20 | 0.64 |
| ▸ | F7 | P08709 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13716969 | 0.93 | ITGB3 (0.55) | ITGB3ITGA2B | |
| SCHEMBL13744972 | 0.92 | ITGB3 (0.61) | ITGB3ITGA2BF7 | |
| SCHEMBL7321771 | 0.89 | ITGB3 (0.71) | ITGB3ITGA2B | |
| SCHEMBL13744829 | 0.88 | ITGB3 (0.65) | ITGB3ITGA2BF7 | |
| SCHEMBL13717015 | 0.87 | ITGB3 (0.63) | ITGB3ITGA2BF7 | |
| SCHEMBL13716655 | 0.87 | ITGB3 (0.46) | ITGB3ITGA2B | |
| SCHEMBL7304352 | 0.85 | ITGB3 (0.66) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7308865 | 0.83 | ITGB3 (0.60) | ITGB3ITGA2B | |
| SCHEMBL7307665 | 0.82 | ITGB3 (0.60) | ITGB3ITGA2BF7 | |
| SCHEMBL13716879 | 0.82 | ITGB3 (0.54) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576071-B2 | Antithrombotic compound | SANOFI-AVENTIS (FR) | 2009-08-18 | — | — | US | disclosed |
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | SANOFI-AVENTIS (FR) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293442-A1 | ANTITHROMBOTIC COMPOUND | F13B, SERPINC1, SELP | ITGB3 66/4885ITGA2B 13/4885F7 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.